Improvements in health‐related quality of life over 3 years with liraglutide 3.0 mg compared with placebo in participants with overweight or obesity

Publisher: John Wiley & Sons Inc

E-ISSN: 1758-8111|8|1|1-10

ISSN: 1758-8103

Source: CLINICAL OBESITY, Vol.8, Iss.1, 2018-02, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract